OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.390
-0.030 (-0.68%)
Nov 21, 2024, 1:09 PM EST - Market open
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $80.87 million as of November 21, 2024. Its market cap has decreased by -49.74% in one year.
Market Cap
80.87M
Enterprise Value
101.01M
1-Year Change
-49.74%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $80.87M, an increase of 136.46%. That is a compound annual growth rate of 14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 81.40M | -68.67% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| I-Mab | 77.61M |
| ESSA Pharma | 77.20M |
| PDS Biotechnology | 77.14M |
| Aerovate Therapeutics | 77.09M |
| P3 Health Partners | 75.44M |
| Renovaro | 75.11M |
| Werewolf Therapeutics | 74.42M |
| MDxHealth | 74.24M |